CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Lantheus Holdings Inc - LNTH CFD

92.55
0.1%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.36
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024346 %
Charges from full value of position ($-4.63)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002124 %
Charges from full value of position ($0.40)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 92.57
Open 94.42
1-Year Change 24.24%
Day's Range 92.29 - 94.42
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 17, 2024 92.57 -0.63 -0.68% 93.20 93.46 91.69
Dec 16, 2024 93.37 0.92 1.00% 92.45 94.96 91.20
Dec 13, 2024 92.98 2.03 2.23% 90.95 93.86 90.95
Dec 12, 2024 91.83 0.28 0.31% 91.55 93.05 91.16
Dec 11, 2024 91.36 0.35 0.38% 91.01 91.59 89.57
Dec 10, 2024 90.93 -1.60 -1.73% 92.53 92.53 89.21
Dec 9, 2024 92.53 2.54 2.82% 89.99 92.61 89.90
Dec 6, 2024 88.94 -0.09 -0.10% 89.03 90.17 87.97
Dec 5, 2024 89.28 1.18 1.34% 88.10 90.66 87.61
Dec 4, 2024 88.72 -0.27 -0.30% 88.99 89.32 86.95
Dec 3, 2024 88.39 -0.80 -0.90% 89.19 89.48 86.65
Dec 2, 2024 89.56 0.11 0.12% 89.45 90.30 88.61
Nov 29, 2024 89.04 -1.41 -1.56% 90.45 90.80 89.04
Nov 27, 2024 90.16 0.23 0.26% 89.93 91.05 89.03
Nov 26, 2024 89.48 -1.03 -1.14% 90.51 91.06 89.00
Nov 25, 2024 90.91 0.80 0.89% 90.11 91.07 88.30
Nov 22, 2024 90.48 2.43 2.76% 88.05 90.82 87.95
Nov 21, 2024 87.27 0.53 0.61% 86.74 88.35 85.04
Nov 20, 2024 86.41 4.58 5.60% 81.83 86.54 81.83
Nov 19, 2024 79.37 3.92 5.20% 75.45 79.58 74.94

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Lantheus Holdings Inc Company profile

About Lantheus Holdings Inc

Lantheus Holdings, Inc. is a provider of imaging diagnostics, targeted therapeutics, and artificial intelligence solutions to Find, Fight and Follow serious medical conditions. It operates through two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its agents and products throughout the United States. The International Segment operations consist of direct distribution in Canada and Puerto Rico, as well as third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific and Latin America and its EXINI business in Sweden. The Company sells its products to radio pharmacies, PET manufacturing facilities (PMFs), integrated delivery networks, hospitals, clinics and group practices. Its commercial portfolio includes DEFINITY, TechneLite, NEUROLITE, RELISTOR, Xenon-133, Cardiolite, Gallium-67, Thallium-201, AZEDRA, QUADRAMET, Cobalt and Automated Bone Scan Index (aBSI).

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Lantheus Holdings Inc revenues increased 25% to $425.2M. Net loss increased from $13.5M to $71.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Other General and administrative increase from $50M to $141.3M (expense), Other Sales and marketing expense increase of 69% to $66M (expense).

Industry: Laboratory Diagnostic & Testing Substances

331 Treble Cove Rd
NORTH BILLERICA
MASSACHUSETTS 01862
US

People also watch

Gold

2,617.00 Price
-0.770% 1D Chg, %
Long position overnight fee -0.0083%
Short position overnight fee 0.0001%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

2.47 Price
-4.530% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01232

BTC/USD

103,674.30 Price
-2.060% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

US100

21,804.20 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0021%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading